Published in Chirurg on January 01, 2005
Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med (1994) 7.17
Multiple essential functions of neuregulin in development. Nature (1995) 5.66
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J Cell Biol (2001) 3.84
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation (2001) 3.33
Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol (1993) 3.32
Characterization of leucocin A-UAL 187 and cloning of the bacteriocin gene from Leuconostoc gelidum. J Bacteriol (1991) 3.02
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity (1996) 2.96
Ultrafast bond softening in bismuth: mapping a solid's interatomic potential with X-rays. Science (2007) 2.84
First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori. Gastroenterology (2001) 2.69
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49
Chemical and genetic characterization of bacteriocins produced by Carnobacterium piscicola LV17B. J Biol Chem (1994) 2.35
CYP98A3 from Arabidopsis thaliana is a 3'-hydroxylase of phenolic esters, a missing link in the phenylpropanoid pathway. J Biol Chem (2001) 2.32
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31
Randomized clinical trial comparing quality of life after straight and pouch coloanal reconstruction. Br J Surg (2002) 2.28
Common-sense models of illness: the example of hypertension. Health Psychol (1985) 2.26
Tailored augmentation of the lower esophageal sphincter in experimental antireflux operations. Surg Endosc (1997) 2.18
Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation (1999) 2.09
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol (1995) 1.91
Quality of life in patients with benign anorectal disorders. Br J Surg (1998) 1.89
Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood (1996) 1.89
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. J Thromb Haemost (2005) 1.88
Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens (2004) 1.86
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group. J Neurol Neurosurg Psychiatry (1998) 1.84
Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem (1984) 1.83
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
Congenital upper eyelid eversion complicated by corneal perforation. Br J Ophthalmol (2005) 1.73
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood (2001) 1.69
Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest (1976) 1.67
Evidence that the Ya and Yc subunits of glutathione transferase B (ligandin) are the products of separate genes. Eur J Biochem (1982) 1.65
Cost-effectiveness of strategies to enhance mammography use. Eff Clin Pract (2001) 1.65
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother (1997) 1.64
Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost (2000) 1.62
Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest (1992) 1.62
Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost (2001) 1.60
Structure-function relationship of human von Willebrand factor. Blood (1987) 1.60
An alternative classification of incisional hernias enlisting morphology, body type and risk factors in the assessment of prognosis and tailoring of surgical technique. J Plast Reconstr Aesthet Surg (2007) 1.58
Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost (1995) 1.58
Thrombotic risk factors in pulmonary hypertension. Eur Respir J (2000) 1.54
Bacterial population of chronic crural ulcers: is there a difference between the diabetic, the venous, and the arterial ulcer? Vasa (2000) 1.52
Agriculture. Transforming U.S. agriculture. Science (2011) 1.51
International survey of patients with von Willebrand disease and angiodysplasia. Thromb Haemost (1993) 1.51
Academic stress, power motivation, and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet (1983) 1.49
Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol (1998) 1.49
Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost (2000) 1.48
Three-dimensional structure of leucocin A in trifluoroethanol and dodecylphosphocholine micelles: spatial location of residues critical for biological activity in type IIa bacteriocins from lactic acid bacteria. Biochemistry (1997) 1.48
A signal peptide secretion-dependent bacteriocin from Carnobacterium divergens. J Bacteriol (1995) 1.42
Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei. J Clin Microbiol (1998) 1.42
[The Würzburg polytrauma algorithm. Concept and first results of a sliding-gantry-based computer tomography diagnostic system]. Anaesthesist (2005) 1.41
[Gardner syndrome and thyroid gland carcinoma]. Langenbecks Arch Chir (1997) 1.39
A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr (2007) 1.38
Long-term follow-up of Stargardt's disease and fundus flavimaculatus. Ophthalmology (1998) 1.37
Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. FEMS Immunol Med Microbiol (2000) 1.36
Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation. Br J Haematol (1974) 1.29
Cloning and developmental expression of the murine neurofilament gene family. Brain Res (1986) 1.28
Procalcitonin in early detection of postoperative complications. Dig Surg (1998) 1.28
The zebrafish forkhead transcription factor FoxH1/Fast1 is a modulator of nodal signaling required for organizer formation. Curr Biol (2000) 1.27
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med (1982) 1.26
Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost (2001) 1.25
Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep (1975) 1.24
Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene. Eur J Hum Genet (1993) 1.24
Characteristics and genetic determinant of a hydrophobic peptide bacteriocin, carnobacteriocin A, produced by Carnobacterium piscicola LV17A. Microbiology (1994) 1.21
Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease. J Lab Clin Med (1980) 1.19
Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies. Blood (1985) 1.18
Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies. Vet Clin Pathol (2005) 1.17
Report from a forum on US heart allocation policy. Am J Transplant (2015) 1.17
Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2. Physiol Behav (2006) 1.15
Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components. EMBO J (2001) 1.14
Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Br J Haematol (1980) 1.14
Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost (1999) 1.14
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost (2006) 1.14
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. J Thromb Haemost (2009) 1.13
Clinical, serologic, and epidemiologic characteristics of ocular toxocariasis. Am J Trop Med Hyg (1979) 1.11
Characteristics of Actinobacillus actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv Dent Res (1995) 1.11
Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). J Thromb Haemost (2004) 1.10
Standard nomenclature for factor VIII and von Willebrand factor: a recommendation by the International Committee on Thrombosis and Haemostasis. Thromb Haemost (1985) 1.10
Ocular complications of dental local anaesthesia. SADJ (1998) 1.10
Characterization of the protein conferring immunity to the antimicrobial peptide carnobacteriocin B2 and expression of carnobacteriocins B2 and BM1. J Bacteriol (1995) 1.10
Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis (1987) 1.09
Vg1 RBP intracellular distribution and evolutionarily conserved expression at multiple stages during development. Mech Dev (1999) 1.09
Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child (1997) 1.09
von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system. Thromb Haemost (2000) 1.07
Purification and partial amino acid sequence of the chloroplast cytochrome b-559. J Biol Chem (1984) 1.07
Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene. Oncogene (1997) 1.07
Genetic characterization and heterologous expression of brochocin-C, an antibotulinal, two-peptide bacteriocin produced by Brochothrix campestris ATCC 43754. Appl Environ Microbiol (1998) 1.06
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med (1983) 1.06
Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost (2000) 1.06
Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Haemost (2005) 1.05
Orbital fractures in children. Arch Otolaryngol Head Neck Surg (1995) 1.04
Multiple founder haplotypes of mitochondrial DNA in Amerindians revealed by RFLP and sequencing. Ann Hum Genet (1996) 1.04
Ocular anomalies simulating double optic discs. Can J Ophthalmol (1981) 1.03
Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes. Eur J Biochem (1993) 1.03
Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol (1996) 1.03
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood (1996) 1.02
New variant of von Willebrand disease with defective binding to factor VIII. Blood (1989) 1.02
What men say about pregnancy, birth and parenthood. J Psychosom Obstet Gynaecol (1996) 1.02
Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs. Am J Cardiol (1990) 1.02
The function of PTB domain proteins. Kidney Int (1999) 1.01